NCT/Study#
NA /
APTEVO
Phase 1-2 Study Of A Bispecific CD3xCD123 Antibody In Acute Myeloid Leukemia Patients
DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
